Autopsy report · NCT03987555
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Cause of deathFunding or business
“Funding”
Life of this trial
- Registered 5 months before it started.
- Suspended: paused, and may or may not restart.
- 55 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Sponsor
- Wake Forest University Health Sciences
- Sponsor type
- University, hospital or other
- Conditions
- Solid Tumor, Adult; Metastatic Nonsmall Cell Lung Cancer; Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Cervical Carcinoma; Metastatic Ovarian Carcinoma; Malignant Uterine Neoplasm
- Interventions
- Blood draws; QLQ-CIPN20 Survey; PR-CTCAE Survey
- Participants
- 55 (planned, not actual)
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.